See what your cells are telling you about your compounds [SBC x Sentinal4D x Revvity]

​Join us to celebrate the arrival of our newly installed Revvity Opera Phenix high-content imaging system and the launch of an exciting collaboration with Sentinal4D.

​The collaboration will enable three biotech companies extract more intelligence from their cells, completely for free.

​Combining the Opera Phenix's advanced cellular imaging capabilities with Sentinal4D's 15 years of research, extensive training datasets and proprietary geometrical-AI models, this new capability will help uncover insights into how a compound affects living cells, including:

• ​🎯 Mechanisms of action – understand how your compounds work.

• ​🔬 On- and off-target effects – identify intended and unintended cellular responses.

• ​💡 Toxicity and efficacy – gain insights to support earlier, more informed decisions.

• ​🧬 Predictive insights – explore how compounds may behave in cellular models you haven't yet tested.

​Whether you're developing new therapeutics or looking to make better-informed decisions earlier in your discovery pipeline, come and discover what this technology could mean for your research.

​Why attend?

• ​See the Opera Phenix in action and hear directly from Revvity about its high-content imaging capabilities.

• ​Discover Sentinal4D's AI-powered approach and how cellular imaging data can be translated into predictions about compound behaviour.

• ​Book a one-to-one session with the Sentinal4D team to discuss your drug discovery challenges.

​Agenda:

​10:00 – Arrival and coffee

​10:20 – Welcome: bringing advanced high-content imaging and AI-predictions to SBC

​10:30 – Revvity Opera Phenix: what can we see?

​10:40 – Sentinal4D: from cellular imaging to insights and predictions + Case studies

​11:00 – Q&A and Opera Phenix viewing

​11:30 – Lunch

​12:00-15.00 - Bookable 1-2-1 slots with Sentinal4D